Reputable and accredited, Acupath is one of just a handful of labs licensed to perform COVID-19 testing on specimens collected in New York State. It is the only privately-owned commercial lab on Long Island that has this capability.
Acupath has tested over 850,000 COVID-19 specimens since May 2020 and offers state-of-the-art technology and reporting services that can be customized to suit individual client needs.
Acupath is a provider of sub-specialized anatomic pathology services focused on the following specialties; Urology, Gastroenterology, Dermatology, Women’s Health, Otolaryngology, Podiatry, and Hematology / Oncology. Acupath offers an extensive pathology test menu on both a global and TC/PC basis, processes over 500,000 specimens annually, and is the first lab worldwide to offer URO17™, an innovative new immunocytochemistry test for the detection of bladder cancer, recently designated as a “Breakthrough Device” by the FDA.
Acupath is accredited by the New York State Department of Health, the Joint Commission, and the College of American Pathologists.